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Background: Post-operative atrial fibrillation is an important complication after coronary bypass surgery. As
inflammation and oxidative stress were makedly encountered in the etiology, high cholesterol was also defined to
provoke atrial fibrillation. In this present study, the relationship between postoperative atrial fibrillation and
preoperative serum lipid levels were evaluated.
Methods: A total of 100 patients, who were operated at the department of Cardiovascular Surgery of our hospital
were included to the study analysis. Patients, who had preoperative atrial fibrillation, thyroid dysfunction, or left
atrial dilatation (above 4.5 cm) were excluded from the study. Patients were divided into two groups with
postoperative atrial fibrillation development (Group I n = 36), and without atrial fibrillation development (Group II
n = 64). Preoperative routine blood analyses, ECG, echocardiography were evaluated. Patients were followed for
atrial fibrillation development for one month starting from the intensive care unit at the postoperative period.
Serum lipid profiles and thyroid function were measured. For homogenization of inflammatory factors and oxidative
stress, treatments other than statins, betablockers, calcium channel blockers, aspirin, ACE inhibitors, and ARB were
stopped for 10 days. Atrial fibrillation for at least ≥5 minutes in the intensive care unit was accepted as
postoperative atrial fibrillation.
Results: Demographic data were similiar between groups (p > 0.05). There was no difference in TC levels between
groups, whereas LDL-C levels were statistically lower in patients developing post-operative atrial fibrillation
(106.67 ± 28.36 vs 118.75 ± 27.75; P < 0.05).
Conclusion: The more lowered is the LDL-C in the preoperative period, the more reduced risk of postoperative
atrial fibrillation development. High levels of LDL-C in the preoperative period could be predictor of atrial fibrillation
development in the post operative period.
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Atrial fibrillation (AF) constitutes a broad area of intense
daily practice for physicians in cardiac arrhytmias. Post-
operative AF differ not only in its development among
cases with myocardial revascularization, but also it has
an incidence of 11-40%. This ratio is evaluated as a com-
plication, which reaches up to 50% among patients with
valvular surgery [1,2]. Moreover, it is the most common
complication, which is encountered during the intensive
care unit stay. It causes increased mechanical ventilation* Correspondence: kilicaslanbaris@yahoo.com
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unless otherwise stated.requirement as well as increased morbidity and mortality
rates by causing vasoactive drug usage [3-5]. Because
postoperative AF has some pathogenetic differences, it is
considered as a model contributing in understanding AF
mechanisms. In large scale studies, the reported inci-
dence is up to 65% in cases with open cardiac surgery,
and it has been reported that transient causes have been
involved in the condition, because recurrence was very
low in the majority of the cases. Because electroanato-
mic abnormalities related to atrial and/or pulmonary
vein, which are basicly required for initiation and continu-
ity of AF are not permenant in these cases, the recurrence
is quite low [6]. Marked predictors of postoperative AF
can be named as age, low ejection fraction, intraoperativetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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Along with the direct relationship between serum choles-
terol levels and atherosclerotic plaques, its correlation has
been found particularly with ventricular arrythmias and
atrial fibrillation [9,10]. Changes in cholesterol content of
cellular membrane may cause formation of the substrate,
which can initiate atrial fibrillation by changing cellular
membrane characteristics, and obtained evidences have
supported that this may be caused by cellular membrane
specific ion channels and pump functions acting the effi-
cacy of hormone specific receptors. When ion channel
characteristics have differed, Ca2 accumulation in the
cellular membrane and sudden changes in the effective
refractory period may cause initiation of AF [11-13].
Therefore, electrical remodelling, which is considered
necessary for continuity of AF, is formed. Serum pre-
operative LDL-C levels could be beneficial in predicting
for postoperative AF independently from lipid lowering
treatments. Although it is well known that preoperative
intense statin treatments could prevent postoperative
AF development, detection of low serum LDL-C level
effect on cardiac myocytes could also be an important
finding. Based on these findings, we investigated the
correlation between postoperative AF and serum lipid
levels in our study.
Methods
A total of 100 cases, which had bypass operation at our
Cardiovascular Surgery clinic, were included in this pro-
spective study. The exclusion criteria for cases were pres-
ence of preoperative AF, left atrial dilation above 4.5 cm,
valvular heart disease, thyroid dysfunction, emergency by-
pass requirement, prior surgical maze and pace-makers.
Patients, who required valvular replacement at the same
session, were included in the study if the left atrial dilation
was not above 4.5 cm. Fasting blood samples of 12 hours
were collected during preoperative preparation period
from all participants to perform routine blood analyses
and serum lipid level measurement. Concomitant beta-
blocker and dyslipidemia treatment was continued in pre-
and postoperative periods. ECG and electrocardiographic
evaluations were performed in all participants (left atrium
period, left ventricular width and ejection fraction were
investigated). Variables related to surgical procedure were
defined and recorded (pump duration, number of vessels
underwent bypass surgery). After the bypass surgery, cases
followed up for at least 48 hours in the intensive care unit
had ECG recordings, and if AF was developed, then they
were defined and recorded. Meanwhile, although ECG
recodings were performed at 12 hours intervals, if there
was any complaint, the ECG was recorded.
Blood samples of cases were collected in the operation
morning after 12-hour fasting to examine serum lipid
profile, thyroid function tests, and fasting blood glucoselevels. ECG recording of each case was performed, and
preoperative sinus rhythm was recorded. Serum lipid
levels were measured by using Hitachi modular D_P
analyzer (Manhaim/Germany).
Our study was approved by the local ethics committee
of Pamukkale University School of Medicine. Our re-
search is in compliance with the Helsinki Declaration.
Statistical methods
Statistical analysis was performed using SPSS 11.0 for
Windows. Data are presented as mean ± SD, controlled
for normally distribution by Kolmogorov-Smirnov test.
Comparison of more than two groups was performed by
using Kruskal-Wallis test with Bonferroni correction and
differences between any two groups were compaired by
Mann-Whitney U test because of abnormal distribution.
Categorical data between two or more groups were
compared by the Pearson χ2 test. A probability value of
p < 0.05 was considered as significant.
Results
Cases underwent bypass surgery (n = 100) were divided
as Group I (n = 36, 36%) (cases developed AF postopera-
tively) and Group 2 (n = 64, 64%) (cases without AF post-
operatively). 36% of patients were developed AF after the
bypass surgery. There was no statistically significant differ-
ence in demographic data except age between the groups
(P < 0.05). We believe that marked homogeneity has been
provided between two groups, because there was no sta-
tistically significant difference in statin usage between the
groups. Groups and statistically analyzed demographic
data are given in Table 1. There was no statistically
significant difference in biochemical results between
groups except LDL cholesterol (LDL-C). (118.75 ± 27.75
vs 106.67 ± 28.36; P < 0.05) (Table 2).
Along with significant difference in preoperative LDL-
C values between the two groups, marked difference in
triglyceride (Group I = 147.17 ± 69.05 mg/dl, Group II =
183.58 ± 114.11 mg/dl; p > 0.05) and VLDL cholesterol
(VLDL-C) arm (Group I = 28.02 ± 10.90 mg/dl, Group
II = 44.51 ± 66.00 mg/dl; p > 0.05) was noteworthy des-
pite the statistical insignificance.
Discussion
AF is a continuous cardiac arrhythmia affecting 0.9% of
the population, and studies conducted to enlighten the
underlying mechanisms have also warranted innovations
in the treatment. In the development of AF, complex rela-
tionships are considered among arrhythmogenic substrate,
triggering factor(s), autonomic nervous system [14]. Oxida-
tive stress and inflammation have a significant role in AF
development have been evolved [15]. Bruin et al. enforced
the inflammation hypothesis by showing the relationship
between postoperative AF and C-reactive protein (CRP)
Table 1 Demographic characteristics of patients
Group I Group II
(n = 36) (n = 64)
Age* 68.50 ± 8.05 62.40 ± 10.52
Gender (female/male) 10/26 13/51
Family history 6 (16.7%) 15 (23.4%)
Smoking history (10 years, 5 cigarettes/d) 20 (55.6%) 32 (50.0%)
Hypertension (BP >139/89 mmHg) 20 (55.6%) 33 (51.6%)
Diabetes mellitus (DM) 11 (30.6%) 25 (39.1%)
Carotis artery lesion 4 (11.1%) 3 (4.7%)
Periferal artery disease 5 (13.9%) 6 (9.4%)
Angina pectoris 20 (55.6%) 41 (64.1%)
Myocardial infarction 5 (13.9%) 19 (29.7%)
Beta-blocker use 19 (52.8%) 34 (53.1%)
Statin use 7 (19.0%) 13 (20.3%)
COPD (using steroid) 5 (13.9%) 4 (6.2%)
Left ventricular ejection fraction (%) 51.63 ± 12.43 50.28 ± 9.88
Body mass index 25.41 ± 3.47 26.64 ± 3.76
*P value for Age is significant (< 0.05) whereas the values are insignificant for
the rest.
Table 2 Comparison of preoperative lipid profiles and
biochemical examinations between the groups
Group I Group II
(n = 36) (n = 64)
WBC 9.27 ± 3.26 9.20 ± 3.32
Hemoglobin 13.22 ± 1.79 13.12 ± 1.87
Hematocrit 38.98 ± 5.39 38.72 ± 5.72
Platellet 252.88 ± 98.16 241.75 ± 80.48
Creatinine, mg/dl 1.08 ± 0.96 1.37 ± 1.63
BUN, mg/dl 20.35 ± 10.98 21.49 ± 17.21
Glucose, mg/dl 129.05 ± 55.96 152.20 ± 68.06
AST, mg/dl* 24.23 ± 14.73 40.65 ± 54.97
ALT, mg/dl 30.51 ± 62.58 33.54 ± 42.46
GGT, U/L 29.77 ± 31.83 39.23 ± 22.57
LDH, mg/dl 275.72 ± 107.32 291.51 ± 167.61
CRP, mg/dl 2.50 ± 3.34 1.67 ± 2.38
Total cholesterol, mg/dl 178.72 ± 46.37 178.27 ± 42.95
LDL-C, mg/dl* 118.75 ± 27.75 106.67 ± 28.36
HDL-C, mg/dl 36.11 ± 9.09 35.80 ± 10.62
Triglyceride, mg/dl 147.17 ± 69.05 183.58 ± 114.11
VLDL-C, mg/dl 28.02 ± 10.90 44.51 ± 66.00
*P value for Age is significant (< 0.05) whereas the values are insignificant for
the rest.
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in persistent AF when compared with paroxysmal AF
suggests that inflammation has a more significant role in
determining the continuity in AF process rather than a
triggering role [17]. In this situation, opinion of the trig-
gering factor presence stands in the foreground in postop-
erative AF. It may be considered that this hypothesis has
been supported by the absence of correlation between pre-
operative CRP levels and postoperative AF in our study.
Role of oxidative stress in pathogenesis of AF has been
shown in human and animal models. Signs related to elec-
trical remodeling and oxidative damage have been rather at
the experimental level. Particularly vitamin C; an antioxi-
dant substance, was reported to prevent AF in preoperative
cases both in human and animal models [18].
Postoperative AF occurs usually on postoperative 2-
3 days [16]. Intense researches have been performed for
its prevention, because it has increased the unfavorable
results such as stroke, congestive heart failure, elong-
ation of hospital stay, and increased need for vasoactive
agents. Majority of these studies have mainly focused on
inflammation suppression and agents decreasing the oxi-
dative stress. Dotani et al. showed that postoperative AF
incidence was markedly decreased by preoperative load
of statins [19]. Ozaydınlı et al. proved that duration of
postoperative AF was also decreased by statin usage
[20]. When all statin studies were evaluated, we noted that
the relationship between preoperative LDL-C levels and
postoperative AF frequency was not sufficiently investi-
gated. Marked increase in LDL-C levels in postoperativeAF cases when compared to the ones without AF has indi-
cated that causative relationship should be investigated.
Cellular membrane and cholesterol content form a
dynamic structure. Changes in membrane cholesterol
content can change functional properties of the mem-
brane. Although formation of these changes has not been
totally understood yet, three mechanisms have been pro-
posed: 1) relationship between cholesterol and membrane
proteins, 2) modulation of membrane fluidity, and 3) rela-
tionship between lipid islets and proteins in the membrane
[21]. These properties of membrane can be controlled by
decreasing serum cholesterol content, and excitability can
be decreased. There are a few studies in the literature
reporting such effects of statins on membrane proteins. It
has been suggested that antiarrhythmic effect has been
exerted through intracellular calcium homeostasis by vari-
ous statin structures at various levels, because intracellular
mevalonate-dependent cholesterol synthesis was inhibited
by statins [22]. We believe that low levels of serum chol-
esterol slow down intracellular LDL-C intake, and also
slow down free cholesterol level through lysosomes. Be-
cause membrane lipid content equilibrium is saved, for-
mation of arrhythmic potentials may be prevented by
the above mentioned mechanisms. Low serum LDL-C
levels, providing the cellular membrane stability, can in-
hibit electrical remodeling by affecting intracellular Ca
levels of triggering factors. It was reported that
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functions were recovered in hypercholesterolemic cases
by applying LDL apheresis once [23,24]. When pleotro-
pic effects of statins have been excluded, it may be
remarked that determination of LDL-C in postoperative
cases; decrease of LDL-C by apheresis application, if the
levels are high; and having the operation are the prevent-
ive factors in AF development.
The patients in group 1 were older than the patients in
group 2. This is the main limitation of our study. Because
this could affect AF prevalence in group 1. However, there
was no statistically significant difference in other demo-
graphic data and we believe that marked homogeneity has
been provided between these two groups.
Conclusion
In conclusion, we think that serum preoperative LDL-C
levels can be beneficial in predicting for postoperative
AF independently from whether patients have received
any lipid lowering treatments. Although it is known that
preoperative intense statin treatments can prevent post-
operative AF development, we believe that detection of
low serum LDL-C level effect on cardiac myocytes is an
important finding. We believe that further large scale
studies are required to evaluate this argument.
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